Results for china national biotec

Add to feed Create your own feed

Latest

The first batch of Chinese#vaccine  aid, developed by Sinopharm's subsidiary China National Biotec Group, arrived in Islamabad on Monday. #Pakistan 's FM Shah Mahmood Qureshi said the vaccines will be given to the country's medics first at the delivery ceremony.

Coronavirus: China National Biotec Group vouches for its vaccine against mutant strains spreading overseas

Development of Chinese #COVID19  vaccine revealed in a documentary. Inactivated COVID-19 vaccine of China National Biotec Group began to be researched in the P4 and P3 laboratory in #Wuhan , which has the highest level of bio-safety protection in #China 

tweet picture

Data shows that the inactivated vaccine developed by Sinopharm is broad-spectrum and can cross-neutralize different #coronavirus  strains, said China National Biotec Group chairman Yang Xiaoming.

tweet picture

Vice president of China National Biotec Group Company (CNBG) said the company is supplementing data of vaccines on people between ages of 3 and 17 in the hope of expanding the population range eligible for inoculation.

tweet picture

A Covid-19 vaccine developed by China National Biotec Group (CNBG), a Sinopharm subsidiary, is safe in those aged between three and 17, based on clinical data obtained by the company.

Chinese regulators granted a first approval for general use to a COVID-19 vaccine to China National Biotec Group’s BBIBP-CorV.

Different efficacy results for a Chinese COVID-19 vaccine released separately in China and in United Arab Emirates are both real and valid, an executive at China National Biotec Group (CNBG) told state media.

A vaccine developed by a unit of China National Biotec Group (CNBG) is 79.34% effective at protecting people from COVID-19 and the company is seeking regulatory approval for general public use in China, the developer said on Wednesday.

A Chinese inactivated vaccine shows 79.34% efficacy against #COVID19 , according to the interim results of the phase-3 clinical trials unveiled by the China National Biotec Group #CNBG ) on Wednesday.

tweet picture

Loading
Loading

Most relevant

China National Biotec Group said Sat that the production capacity of its #COVID19  vaccine is expected to reach 1 bln doses in 2021. The current workshops in Beijing and Wuhan have an annual output of 300 mln. The construction of more workshops will be completed by the year-end.

tweet picture

State-backed vaccine maker China National Biotec Group is hopeful of two of its coronavirus vaccine candidates receiving conditional regulatory approval for general public use within the year, its vice president said

China National Biotec Group said it will donate 200,000 doses of its candidate coronavirus vaccine to the central city of Wuhan, where the virus first emerged late last year

Four more countries have agreed to run late-stage clinical tests of coronavirus vaccine candidates from China National Biotec Group and Sinovac Biotech as China steps up its efforts in the global race

China National Biotec Group and Sinovac Biotech said four more countries have agreed to run late-stage clinical tests of their coronavirus vaccine candidates

The United Arab Emirates and China have launched a Phase 3 clinical trial of a coronavirus vaccine, according to the China National Biotec Group and UAE state media. The collaboration is not the only vaccine at the Phase 3 stage.

32 recovered #COVID19  patients have donated 10,650 ml of plasma by Sat, said China National Biotec Group, a state-owned biological products maker. The company announced on Fri that it has developed convalescent plasma to treat patients with novel coronavirus pneumonia.

tweet picture

Loading
Loading